{
    "title": "Bristol Myers boosts cancer drug portfolio with $4.1 bln Turning Point deal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10881833/Bristol-Myers-buy-Turning-Point-Therapeutics-4-1-bln.html",
    "date": "2022-06-03",
    "keywords": [
        "drug",
        "bristol",
        "cancer",
        "deal",
        "repotrectinib",
        "market",
        "khandekar",
        "co",
        "point",
        "cell",
        "share",
        "year",
        "lung",
        "june",
        "friday",
        "developer",
        "cash",
        "arsenal",
        "body",
        "growth",
        "premium",
        "closing",
        "price",
        "time",
        "dearth",
        "investor",
        "easing",
        "biotech",
        "street",
        "sector",
        "sentiment",
        "latetomarket",
        "oncology",
        "analyst",
        "bradley",
        "canino",
        "trading",
        "class",
        "kinase",
        "nsclc",
        "opdivo",
        "roche",
        "merck",
        "inc",
        "astrazeneca",
        "therapy",
        "treatment",
        "keytruda",
        "approval",
        "half",
        "reporting",
        "bengaluru",
        "editing",
        "maju",
        "samuel",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}